TANDEM DIABETES CARE INC
TNDMNASDAQ🏆 #2401 by market capEarnings Nov 5US Equity
$16.57▲ $0.15 (+0.91%)
🌙 After hours$16.60▲ 0.18%Regular close · extended-hours price shownTrack TNDM
Get earnings, price moves & breaking news on Telegram
24h▲ 0.9%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$1.14B
Small Cap
📈Revenue Growth (YoY)
+7.9%
Slowing
📊Gross Margin
56.0%
Healthy
💵FCF Margin
-2.6%
Thin
⚖️P/S Ratio
1.1x
Cheap
Otter Score
88
Very Good
TANDEM DIABETES CARE INC
TNDMAnalyst Ratings
Price
$16.57
Total
39
Raised
7
Lowered
4
Avg PT
$30.17
H / L
$55 / $16
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Truist Securities | Reiterated | Buy | 2026-09-24 | — | — |
Citigroup | Reiterated | Neutral | 2026-08-07 | — | — |
RBC Capital | Reiterated | Outperform | 2026-08-07 | $26.00 | +56.90% |
Mizuho | Reiterated | Neutral | 2026-07-15 | — | — |
Deutsche Bank | Downgraded | Buy → Hold | 2026-06-23 | $15.50 | −6.50% |
Wells Fargo | Upgraded | Equal Weight → Overweight | 2026-06-01 | $27.00 | +62.90% |
B of A Securities | Reiterated | Neutral | 2026-05-18 | — | — |
Barclays | Reiterated | Overweight | 2026-05-11 | $55.00 | +231.90% |
TD Cowen | Reiterated | Buy | 2026-04-20 | — | — |
Goldman Sachs | Reiterated | Neutral | 2026-04-09 | $21.00 | +26.70% |
Piper Sandler | Upgraded | Neutral → Overweight | 2026-03-17 | $21.00 | +26.70% |
Morgan Stanley | Reiterated | Equal Weight | 2026-03-02 | $23.00 | +38.80% |
Lake Street | Upgraded | Hold → Buy | 2026-02-23 | $50.00 | +201.80% |
Stifel | Reiterated | Hold | 2026-02-20 | — | — |
UBS | Reiterated | Neutral | 2026-02-20 | $18.00 | +8.60% |
Bernstein | Reiterated | Market Perform | 2026-01-09 | $25.00 | +50.90% |
Canaccord Genuity | Reiterated | Buy | 2025-12-17 | $40.00 | +141.40% |
Baird | Upgraded | Neutral → Outperform | 2025-12-16 | — | — |
Oppenheimer | Reiterated | Outperform | 2025-09-08 | $22.00 | +32.80% |
Leerink Partners | Upgraded | Market Perform → Outperform | 2024-04-25 | $45.00 | +171.60% |
Jefferies | Reiterated | Buy | 2023-10-02 | — | — |
Craig-Hallum | Reiterated | Buy | 2023-06-13 | $153.00 | +823.40% |
Raymond James | Downgraded | Outperform → Market Perform | 2023-04-24 | $92.00 | +455.20% |
Cowen & Co. | Reiterated | Outperform | 2023-02-23 | $141.00 | +750.90% |
Wolfe Research | Reiterated | Peer Perform → Perform | 2023-01-26 | — | — |
OTR Global | Downgraded | Positive → Mixed | 2022-09-07 | — | — |
SVB Leerink | Reiterated | Market Perform | 2022-05-05 | — | — |
Stifel Nicolaus | Reiterated | Hold | 2020-02-25 | $22.00 | +32.80% |
Guggenheim | Reiterated | Buy | 2019-10-18 | — | — |
BMO Capital | Reiterated | Outperform | 2019-03-08 | — | — |
Berenberg | Reiterated | Buy | 2018-08-30 | — | — |
Dougherty | Reiterated | Buy | 2018-08-24 | — | — |
Bank of America | Upgraded | Underperform → Neutral | 2018-08-24 | — | — |
PiperJaffray | Upgraded | Neutral → Overweight | 2018-05-14 | — | — |
Feltl & Co. | Downgraded | Strong Buy → Buy | 2016-11-02 | — | — |
Wedbush | Reiterated | Outperform | 2016-11-02 | — | — |
B. Riley FBR | Reiterated | Buy | 2016-09-27 | — | — |
B. Riley | Reiterated | Buy | 2016-09-27 | — | — |
William Blair | Reiterated | Outperform | 2014-07-15 | — | — |
Institution
Truist Securities
Reiterated · Buy · 2026-09-24
—
—
Citigroup
Reiterated · Neutral · 2026-08-07
—
—
RBC Capital
Reiterated · Outperform · 2026-08-07
$26.00
+56.90%
Mizuho
Reiterated · Neutral · 2026-07-15
—
—
Deutsche Bank
Downgraded · Buy → Hold · 2026-06-23
$15.50
−6.50%
Wells Fargo
Upgraded · Equal Weight → Overweight · 2026-06-01
$27.00
+62.90%
B of A Securities
Reiterated · Neutral · 2026-05-18
—
—
Barclays
Reiterated · Overweight · 2026-05-11
$55.00
+231.90%
TD Cowen
Reiterated · Buy · 2026-04-20
—
—
Goldman Sachs
Reiterated · Neutral · 2026-04-09
$21.00
+26.70%
Piper Sandler
Upgraded · Neutral → Overweight · 2026-03-17
$21.00
+26.70%
Morgan Stanley
Reiterated · Equal Weight · 2026-03-02
$23.00
+38.80%
Lake Street
Upgraded · Hold → Buy · 2026-02-23
$50.00
+201.80%
Stifel
Reiterated · Hold · 2026-02-20
—
—
UBS
Reiterated · Neutral · 2026-02-20
$18.00
+8.60%
Bernstein
Reiterated · Market Perform · 2026-01-09
$25.00
+50.90%
Canaccord Genuity
Reiterated · Buy · 2025-12-17
$40.00
+141.40%
Baird
Upgraded · Neutral → Outperform · 2025-12-16
—
—
Oppenheimer
Reiterated · Outperform · 2025-09-08
$22.00
+32.80%
Leerink Partners
Upgraded · Market Perform → Outperform · 2024-04-25
$45.00
+171.60%
Jefferies
Reiterated · Buy · 2023-10-02
—
—
Craig-Hallum
Reiterated · Buy · 2023-06-13
$153.00
+823.40%
Raymond James
Downgraded · Outperform → Market Perform · 2023-04-24
$92.00
+455.20%
Cowen & Co.
Reiterated · Outperform · 2023-02-23
$141.00
+750.90%
Wolfe Research
Reiterated · Peer Perform → Perform · 2023-01-26
—
—
OTR Global
Downgraded · Positive → Mixed · 2022-09-07
—
—
SVB Leerink
Reiterated · Market Perform · 2022-05-05
—
—
Stifel Nicolaus
Reiterated · Hold · 2020-02-25
$22.00
+32.80%
Guggenheim
Reiterated · Buy · 2019-10-18
—
—
BMO Capital
Reiterated · Outperform · 2019-03-08
—
—
Berenberg
Reiterated · Buy · 2018-08-30
—
—
Dougherty
Reiterated · Buy · 2018-08-24
—
—
Bank of America
Upgraded · Underperform → Neutral · 2018-08-24
—
—
PiperJaffray
Upgraded · Neutral → Overweight · 2018-05-14
—
—
Feltl & Co.
Downgraded · Strong Buy → Buy · 2016-11-02
—
—
Wedbush
Reiterated · Outperform · 2016-11-02
—
—
B. Riley FBR
Reiterated · Buy · 2016-09-27
—
—
B. Riley
Reiterated · Buy · 2016-09-27
—
—
William Blair
Reiterated · Outperform · 2014-07-15
—
—
One row per institution · price target from the firm's latest published target